Related Experiment Video
Updated: Jul 4, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Sexual dimorphism in melanocyte stem cell behavior reveals combinational therapeutic strategies for cutaneous
Luye An1, Dahihm Kim1, Leanne R Donahue1
1Department of Biomedical Sciences, Cornell University, Ithaca, NY, 14850, USA.
Abstract:
Vitiligo is an autoimmune skin disease caused by cutaneous melanocyte loss. Although phototherapy and T cell suppression therapy have been widely used to induce epidermal re-pigmentation, full pigmentation recovery is rarely achieved due to our poor understanding of the cellular and molecular mechanisms governing this process. Here, we identify unique melanocyte stem cell (McSC) epidermal migration rates between male and female mice, which is due to sexually dimorphic cutaneous inflammatory responses generated by ultra-violet B exposure. Using genetically engineered mouse models, and unbiased bulk and single-cell mRNA sequencing approaches, we determine that manipulating the inflammatory response through cyclooxygenase and its downstream prostaglandin product regulates McSC proliferation and epidermal migration in response to UVB exposure. Furthermore, we demonstrate that a combinational therapy that manipulates both macrophages and T cells (or innate and adaptive immunity) significantly promotes epidermal melanocyte re-population. With these findings, we propose a novel therapeutic strategy for repigmentation in patients with depigmentation conditions such as vitiligo.
Insights
Researchers discovered that manipulating inflammatory responses in mice can improve melanocyte stem cell (McSC) migration and proliferation, offering a new therapeutic strategy for vitiligo and other depigmentation disorders.
Area of Science:
- Dermatology
- Immunology
- Stem Cell Biology
Background:
- Vitiligo is an autoimmune skin condition resulting in melanocyte loss.
- Current treatments like phototherapy and T cell suppression show limited efficacy due to incomplete understanding of repigmentation mechanisms.
Purpose of the Study:
- To investigate the mechanisms governing melanocyte stem cell (McSC) migration and proliferation in response to ultraviolet B (UVB) exposure.
- To identify novel therapeutic targets for enhancing epidermal repigmentation in depigmentation disorders.
Main Methods:
- Utilized genetically engineered mouse models.
- Employed unbiased bulk and single-cell mRNA sequencing.
- Investigated the role of cyclooxygenase and prostaglandin pathways in regulating McSC behavior.
- Assessed the efficacy of combined innate and adaptive immune manipulation therapies.
Main Results:
- Identified sexually dimorphic differences in McSC epidermal migration rates linked to UVB-induced inflammatory responses.
- Demonstrated that modulating cyclooxygenase and prostaglandin pathways influences McSC proliferation and migration.
- Showed that a combination therapy targeting macrophages and T cells significantly enhances epidermal melanocyte repopulation.
Conclusions:
- Sexually dimorphic inflammatory responses impact McSC behavior after UVB exposure.
- Targeting inflammatory pathways, specifically cyclooxygenase and prostaglandins, offers a viable strategy to regulate McSC function.
- Combined manipulation of innate and adaptive immunity presents a promising novel therapeutic approach for vitiligo and other depigmentation conditions.
Related Concept Videos
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Multipotency and Niche of Bulge Stem Cell
Forced Transdifferentiation
Artificial...
iPS Cell Differentiation

